Trial Profile
Efficacy of Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Glutamine (Primary) ; Alanine
- Indications Short bowel syndrome
- Focus Therapeutic Use
- 28 Jul 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Apr 2015 New trial record